XML 26 R15.htm IDEA: XBRL DOCUMENT
v3.21.1

Note 8 - Concentrations of Credit Risk | 6 Months Ended
--- | ---
Apr. 30, 2021
Notes to Financial Statements |
Concentration Risk Disclosure [Text Block] | Note 8 – Concentrations of credit risk Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. We maintain our cash and cash equivalents with high-credit quality financial institutions. At April 30, 2021, we had cash and cash equivalent balances in excess of federally insured limits in the amount of approximately $13.4 million. Two customers, both distributors, accounted for approximately 12% and 11% of net sales for the three months ended April 30, 2021, and 14% and 11%, respectively, of net sales for the six months ended April 30, 2021. These distributors had accounts receivable balances that accounted for 14% and 13%, respectively, of the total net accounts receivable balance at April 30, 2021. The two distributors also accounted for 17% and 11% of net sales for the three months ended April 30, 2020, and 14% and 11%, respectively, of net sales for the six months ended April 30, 2020. In the same six-month period, another customer, a wireless carrier, accounted for 11% of net sales. The two distributors had accounts receivable balances that accounted for 19% and 14%, respectively, of the total net accounts receivable balance at April 30, 2020. Although these customers have been on-going major customers of the Company, the written agreements with these customers do not have any minimum purchase obligations and they could stop buying our products at any time and for any reason. A reduction, delay or cancellation of orders from these customers or the loss of these customers could significantly reduce our future revenues and profits.

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -URI http://asc.fasb.org/topic&trid=2134479 + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration